Nemaura Medical Inc. (NMRD): Price and Financial Metrics

Nemaura Medical Inc. (NMRD): $0.05

0.00 (-9.46%)

POWR Rating

Component Grades

Momentum

D

Stability

C

Sentiment

Quality

D

NMRD Price/Volume Stats

Current price $0.05 52-week high $1.25
Prev. close $0.05 52-week low $0.03
Day low $0.05 Volume 38,400
Day high $0.05 Avg. volume 69,930
50-day MA $0.05 Dividend yield N/A
200-day MA $0.16 Market Cap 1.82M

NMRD Stock Price Chart Interactive Chart >


Nemaura Medical Inc. (NMRD) Company Bio


Nemaura Medical Inc. designs and develops proprietary drug delivery platforms. The Company produces therapeutic delivery systems including patches and injectors. Nemaura Medical offers its products to the pharmaceutical and healthcare industries.


NMRD Latest News Stream


Event/Time News Detail
Loading, please wait...

NMRD Latest Social Stream


Loading social stream, please wait...

View Full NMRD Social Stream

Latest NMRD News From Around the Web

Below are the latest news stories about NEMAURA MEDICAL INC that investors may wish to consider to help them evaluate NMRD as an investment opportunity.

Nemaura Medical Inc. Receives Positive Nasdaq Listing Decision

Loughborough, UK, Dec. 13, 2023 (GLOBE NEWSWIRE) -- Nemaura Medical Inc. (NASDAQ: NMRD) (“Nemaura Medical” or the “Company”), developer of a daily wear non-invasive glucose sensor, and digital healthcare programs is pleased to announce that the Nasdaq Hearings Panel granted the Company’s request for continued listing pursuant to an exception, including certain interim milestones, that ultimately expires on April 1st, 2024, to evidence compliance with all applicable criteria for continued listing

Yahoo | December 13, 2023

Nemaura Medical Inc. Secures $10 Million Non-Dilutive Credit Facility to Fuel Strategic Growth

Loughborough, UK, Nov. 21, 2023 (GLOBE NEWSWIRE) -- Nemaura Medical Inc. (NASDAQ: NMRD) (“Nemaura Medical” or the “Company”), developer of a daily wear non-invasive glucose sensor, and digital healthcare programs is pleased to announce the execution of a strategic agreement for a $10 million credit facility which is expected to support the Company’s strategic growth plans. Recognizing the challenges associated with equity sales, particularly in the small-cap landscape on the Nasdaq, Nemaura Medi

Yahoo | November 21, 2023

Nemaura (NMRD) to Expand in UK With Metabolic Health Program

The latest program leverages Nemaura's (NMRD) world-first daily wear non-invasive CGM technology, providing individuals with real-time insights into their body's glucose dynamics.

Yahoo | November 17, 2023

Nemaura Medical First Half 2024 Earnings: US$0.13 loss per share (vs US$0.33 loss in 1H 2023)

Nemaura Medical ( NASDAQ:NMRD ) First Half 2024 Results Key Financial Results Net loss: US$3.81m (loss narrowed by 52...

Yahoo | November 16, 2023

Sidoti Events, LLC’s Virtual November Micro-Cap Conference

NEW YORK, NY / ACCESSWIRE / November 14, 2023 / Sidoti Events, LLC, an affiliate of Sidoti & Company, LLC, has released the presentation schedule and weblinks for its two-day November Micro-Cap Conference taking place Wednesday and Thursday, November ...

Yahoo | November 14, 2023

Read More 'NMRD' Stories Here

NMRD Price Returns

1-mo 6.38%
3-mo -31.69%
6-mo -72.07%
1-year -92.31%
3-year -99.48%
5-year -99.43%
YTD -77.17%
2023 -87.25%
2022 -62.34%
2021 20.95%
2020 7.71%
2019 -61.11%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!